Aimei Health Technology Co., Ltd
AFJK
$11.30
$0.090.80%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -89.94% | 2.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -89.94% | 2.84% | |||
| Operating Income | 89.94% | -2.84% | |||
| Income Before Tax | 130.10% | -58.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 130.10% | -58.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 130.10% | -58.41% | |||
| EBIT | 89.94% | -2.84% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 173.23% | -48.37% | |||
| Normalized Basic EPS | 174.68% | -48.70% | |||
| EPS Diluted | 173.23% | -48.37% | |||
| Normalized Diluted EPS | 174.68% | -48.70% | |||
| Average Basic Shares Outstanding | -15.95% | -19.31% | |||
| Average Diluted Shares Outstanding | -15.95% | -19.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||